Sun Pharma invests $25 million in Pharmazz Inc for drug candidates Sovateltide and Centhaquine, with potential licensing ...

From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study ...

The awards are subject to the terms and conditions of the Inducement Plan and the terms and conditions of the RSU agreement covering the grant. The awards are being granted as an inducement material ...

Qamzova is a non-steroidal anti-inflammatory that provides 24-hour pain relief in a single shot, reducing post-surgery opioid ...

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar ...

Speakers: Andrew Oxtoby, Chief Executive Officer & Matthew Feinsod, Chief Medical Officer Date: Tuesday, May 27 th, 2025 Kalaris is a clinical-stage biopharmaceutical company dedicated to the ...

Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates ...

The rise of GLP-1 agonist therapies has transformed obesity treatment, delivering unprecedented results and revealing their ...

Shares of Exelixis, Inc. (EXEL), an oncology-focused biopharmaceutical firm, boosted by Big Money inflows.

Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from ...